News
Viking Therapeutics offers a speculative opportunity, driven by its promising obesity drug pipeline. Click here to read more ...
Explore Blink Charging Co.'s Q2 2025 earnings call insights, highlighting 73% product revenue growth, cost reductions, Zemetric acquisition, and plans ...
Blink Charging Co. ( NASDAQ: BLNK) Q2 2025 Earnings Conference Call August 18, 2025 4:30 PM ET Michael Bercovich - Corporate Participant Michael C. Battaglia - President, CEO & Director Vitalie Stelea ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback